product summary
company name :
Hycult Biotech
product type :
antibody
product name :
C3, Mouse, mAb 11H9
catalog :
HM1045
quantity :
100 µg
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
11H9
reactivity :
mouse
application :
western blot, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
Hycult Biotech product webpage
citations: 9
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - frozen section; mouse; 1:20; loading ...; fig 4b
Neher M, Rich M, Keene C, Weckbach S, Bolden A, Losacco J, et al. Deficiency of complement receptors CR2/CR1 in Cr2?/? mice reduces the extent of secondary brain damage after closed head injury. J Neuroinflammation. 2014;11:95 pubmed publisher
Ma W, Cojocaru R, Gotoh N, Gieser L, Villasmil R, Cogliati T, et al. Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation. Neurobiol Aging. 2013;34:2310-21 pubmed publisher
Barata L, Miwa T, Sato S, Kim D, Mohammed I, Song W. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack. J Immunol. 2013;190:2886-95 pubmed publisher
Lewis R, Perry M, Guschina I, Jackson C, Morgan B, Hughes T. CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism. Am J Pathol. 2011;179:1601-7 pubmed publisher
Heurich B, El Idrissi N, Donev R, Petri S, Claus P, Neal J, et al. Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis. J Neuroimmunol. 2011;235:104-9 pubmed publisher
Scalapino K, Daikh D. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells. PLoS ONE. 2009;4:e6031 pubmed publisher
Scalapino K, Tang Q, Bluestone J, Bonyhadi M, Daikh D. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol. 2006;177:1451-9 pubmed
Windbichler M, Echtenacher B, Takahashi K, Ezekowitz R, Schwaeble W, Jenseniuis J, et al. Investigations on the involvement of the lectin pathway of complement activation in anaphylaxis. Int Arch Allergy Immunol. 2006;141:11-23 pubmed
Singbartl K, Bockhorn S, Zarbock A, Schmolke M, Van Aken H. T cells modulate neutrophil-dependent acute renal failure during endotoxemia: critical role for CD28. J Am Soc Nephrol. 2005;16:720-8 pubmed
product information
Catalog no :
HM1045
Title :
C3, Mouse, mAb 11H9
Clone no :
11H9
Quantity :
100 µg
Application code :
frozen sections,flow cytometry,immunoassays,immunoprecipitation,paraffin sections,western blot
Species :
mouse
Host species :
rat
Isotype :
IgG2a
Conjugate :
purified
Aliases :
complement component 3
Type :
mAb
Antigen :
C3
Meta data :
complement component 3
more info or order :
Hycult Biotech product webpage
company information
Hycult Biotech
Frontstraat 2a
5405 PB UDEN
support@hycultbiotech.com
www.hycultbiotech.com
31 0 413 25 13 35
headquarters: Netherlands
Hycult Biotech develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.

As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.